Prostate cancer: Three drug trials to watch
Merck says Keytruda injection on par with approved IV version in trial
Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
Future of Medicare drug price negotiations under new administration: 5 things to know
*please scroll down for all the latest news*
